Copy number amplification of TTPAL promotes cholesterol biosynthesis and esophageal squamous cell carcinoma progression via elevating NSUN2-mediated m5C modification of SREBP2 mRNA. [PDF]
Huang S +16 more
europepmc +3 more sources
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA [PDF]
Endometrial cancer (EC) is a prevalent gynecological malignancy worldwide, and 5-methylcytosine (m5C) modification of mRNA is a crucial epigenetic modification associated with the development and occurrence of several cancers.
Shuai-Jun Chen +7 more
doaj +2 more sources
Comprehensive analysis of key m5C modification-related genes in type 2 diabetes. [PDF]
Background: 5-methylcytosine (m5C) RNA methylation plays a significant role in several human diseases. However, the functional role of m5C in type 2 diabetes (T2D) remains unclear.Methods: The merged gene expression profiles from two Gene Expression Omnibus (GEO) datasets were used to identify m5C-related genes and T2D-related differentially expressed ...
Song Y +7 more
europepmc +4 more sources
Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma [PDF]
Zhen Sun +8 more
openalex +3 more sources
NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC. [PDF]
Wu L, Chen B, Cheng S, Fang X, Zhou F.
europepmc +2 more sources
The role of m5C RNA modification in cancer development and therapy
RNA modifications have been demonstrated to affect the function, stability, processing, and interactions of RNA, including pseudouridylation, acetylation and methylation. RNA methylation products, such as N6-methyladenosine (m6A), 5-methylcytidine (m5C), N7-methylguanosine (m7G), 2'-O-dimethyladenosine (m6Am), and N1-methyladenosine (m1A), have been ...
Li Yu +5 more
openalex +3 more sources
Multi-omics analysis reveals that ALYREF-mediated m<sup>5</sup>C modification promotes platinum resistance in ovarian cancer via the NSUN2/ALYREF/LGR4 axis. [PDF]
Yang S, He P, Wang W, Xu X, Xi X, Li Y.
europepmc +2 more sources
RNF115 upregulation by YBX1-dependent m5C modification promotes hepatocellular carcinoma progression. [PDF]
Li J, Chen H, Bai L, Tang H.
europepmc +2 more sources
Isoimperatorin improves osteoporosis by increasing YBX1 expression to promote BGLAP m5C modification. [PDF]
Osteoporosis is a chronic metabolic bone disease that is prone to fractures. Isoimperatorin (ISO) has been shown to alleviate the bone loss in ovariectomized (OVX) rats. The aim of this study was to investigate the effect and the mechanism of ISO on osteoporosis using animal study and cell experiments.
Hu G, Wen J, Yang H, Zhang K.
europepmc +4 more sources

